GlassScriptPhysician profile
Keith S Thompson
NPI 1598751877
$665.78
in general payments reported to CMS, 2019-2025
14 companies · $35.03 in 2025
The $35.03 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $45.81 · 2021: $89.73 · 2022: $194 · 2023: $189 · 2025: $35.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $224.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $135.03 | 2019-2025 | |
| Sanofi Pasteur INC. | $93.24 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $59.35 | 2022-2023 | Gardasil 9, Vaxelis, Vaxneuvance |
| Glaxosmithkline, LLC. | $58.55 | 2020-2023 | Bexsero, Pediarix |
| Takeda Pharmaceuticals U.S.A., INC. | $50.18 | 2019-2022 | |
| Sobi, INC | $46.41 | 2022-2023 | |
| Ironshore Pharmaceuticals INC. | $39.67 | 2019-2020 | |
| Seqirus USA INC | $39.28 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $38.50 | 2021-2022 | |
| Cranial Technologies, INC | $32.78 | 2023 | Doc Band |
| Verrica Pharmaceuticals INC. | $22.83 | 2023 | Ycanth |
| Janssen Biotech, INC. | $19.99 | 2023 | Erleada |
| Novo Nordisk INC | $15.62 | 2019 | |
| Alexion Pharmaceuticals, INC. | $14.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.